Ornithine decarboxylase mRNA is stabilized in an mTORC1-dependent manner in Ras-transformed cells.
NIH Public Access
Author Manuscript
Biochem J. Author manuscript; available in PMC 2013 February 15.
Published in final edited form as:
Biochem J. 2012 February 15; 442(1): 199–207. doi:10.1042/BJ20111464.
Ornithine decarboxylase mRNA is stabilized in an mTORC1dependent manner in Ras-transformed cells
$watermark-text
Sofia Origanti*,1, Shannon L. Nowotarski*,2, Theresa D. Carr*, Suzanne Sass-Kuhn*, Lan
Xiao†,‡, Jian-Ying Wang†,‡,§, and Lisa M. Shantz*
*Department of Cellular and Molecular Physiology, Penn State College of Medicine, Hershey, PA
17033, USA
†Cell
Biology Group, Department of Surgery, University of Maryland School of Medicine,
Baltimore, MD 21201, U.S.A
‡Department
of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201,
U.S.A
§Baltimore
Veterans Affairs Medical Center, Baltimore, MD 21201, U.S.A
$watermark-text
SYNOPSIS
$watermark-text
Upon ras activation, ornithine decarboxylase (ODC) is markedly induced, and numerous studies
suggest that ODC expression is controlled by Ras effector pathways. ODC is therefore a potential
target in the treatment and prevention of Ras-driven tumors. We compared ODC mRNA
translation profiles and stability in normal and Ras12V-transformed rat intestinal epithelial
(RIE-1) cells. While translation initiation of ODC increased modestly in Ras12V cells, ODC RNA
was stabilized 8-fold. Treatment with the specific mTORC1 inhibitor rapamycin or siRNA
knockdown of mTOR destabilized the ODC message, but rapamycin had only a minor effect on
ODC translation initiation. Inhibition of mTORC1 also reduced the association of the mRNA
binding protein HuR with the ODC transcript. We have shown previously that HuR binding to the
ODC 3′UTR results in significant stabilization of the ODC mRNA, which contains several AUrich regions within its 3′UTR that may act as regulatory sequences. Analysis of ODC 3′UTR
deletion constructs suggests that cis-acting elements between bases 1969 and 2141 of the ODC
mRNA act to stabilize the ODC transcript. These experiments thus define a novel mechanism of
ODC synthesis control. Regulation of ODC mRNA decay could be an important means of limiting
polyamine accumulation and subsequent tumor development.
Keywords
ornithine decarboxylase; mRNA stability; translation initiation; mTOR; rapamycin; HuR
Corresponding author: Lisa M. Shantz, Ph.D., Associate Professor, Department of Cellular and Molecular Physiology H166, Room
C4731, The Penn State College of Medicine, 500 University Drive, Hershey, PA 17033, USA, phone: 717-531-1562, fax:
717-531-7667, .
1Current address: Sofia Origanti, Ph.D., Department of Cell Biology and Physiology, Washington University School of Medicine,
St. Louis, MO 63110, USA
2Current address: Shannon L. Nowotarski, Ph.D., The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins
University School of Medicine, Baltimore, MD 21231, USA
AUTHOR CONTRIBUTIONS: Sofia Origanti performed the majority of the experiments and was involved in writing and editing
the manuscript. Shannon Nowotarski, Theresa Carr, Suzanne Sass-Kuhn and Lian Xiao performed some of the experiments. Jian-Ying
Wang provided reagents and critical reading of the manuscript. Lisa Shantz had the original idea, secured funding, and was involved
in writing and editing the manuscript.
Origanti et al.
Page 2
INTRODUCTION
$watermark-text
Increased activity of ornithine decarboxylase (ODC), the first biosynthetic enzyme of the
polyamine pathway, has been demonstrated in a variety of human malignancies, including
prostate cancer, squamous cell carcinoma of the skin and colon cancer (reviewed in [1]).
Intracellular levels of ODC are tightly regulated, and multiple means of ODC dysregulation
can occur in response to oncogenic stimuli. We have used in vitro and in vivo models of Ras
activation to establish that ODC activity is regulated by and necessary for Ras-dependent
cellular transformation, as well as transformation brought about by the Ras effectors MEK
and eIF4E [2–5]. Activation of ODC transcription and protein synthesis is dependent on
pathways downstream of Raf/MEK/ERK and PI3K/mTOR in both fibroblast and epithelial
models [3, 6]. The cooperation of pathways controlled by Raf and PI3K/mTOR is necessary
for complete Ras transformation of several types of epithelial cells (reviewed in [7]). Since
most solid tumors are epithelial in origin, understanding how ODC synthesis is controlled by
these pathways is crucial in defining the role of ODC in maintaining a transformed
phenotype.
$watermark-text
Cap-dependent translational regulation of ODC through its 5′-untranslated region (5′UTR)
is well-established, and ODC activity and translation are induced in eIF4E-overexpressing
fibroblasts (4E-P2 cells) [2, 8]. However, our studies in rat intestinal epithelial cells (RIE-1
cells) described here suggest an alternate post-transcriptional regulatory mechanism for
ODC protein synthesis. In this system, ODC synthesis is regulated primarily by changes in
the levels of ODC RNA associated with polysomes, rather than changes in translation
initiation. The mechanism of this regulation is a marked stabilization of the ODC mRNA in
Ras12V-transformed RIE-1 cells (Ras12V cells) compared to their nontransformed parental
controls, which appears to be regulated at least in part by pathways downstream of mTOR
Complex 1 (mTORC1). Although the primary function of mTORC1 is in controlling the
availability of eIF4E for translation initiation (reviewed in [9]), several studies show that
TOR inhibition results in RNA stabilization. In S. Cerevisiae inhibition of TORC1 using the
specific inhibitor rapamycin induced destabilization of multiple mRNAs, suggesting that
TORC1 functions also involve regulation of mRNA turnover [10, 11]. In mammalian
systems, rapamycin treatment of mouse embryo fibroblasts increased the degradation of
mRNAs corresponding to Cyclin D1 and c-Myc in an Akt-dependent manner [12], while
treatment of breast cancer MDA-MB-231 cells with rapamycin resulted in destabilization of
IL-8 mRNA [13].
$watermark-text
Regulation of mRNA stability is recognized to play a pivotal role in controlling gene
expression. Sequences defined as adenylate- and uridylate-rich elements (AREs), which are
classified based on the number and context of the sequence 5′-AUUUA-3′, are present
within the 3′UTRs of many proto-oncogene, transcription factor and cytokine mRNAs
(reviewed in [14, 15]), and can act as determinants of mRNA stability. The mouse, rat and
human ODC 3′UTR sequences, each of which is between 600–700 bases in length, have
several potential AREs within approximately 300 bases the stop codon. A number of
regulatory proteins are known to interact with ARE sequences. These proteins not only
control transcript decay, but can also influence translational efficiency, or cause the bound
RNA transcript to move to a processing body (P-body) for storage [16]. We have shown
recently that the ubiquitous member of the E (...truncated)